References: Sharief,M.K.. Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis. Eur.J.Neurol. 2002;9:49-54. (Link)
Schwarz,H.; Tuckwell,J.; Lotz,M.. A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. Gene 1993;134:295-298. (Link)
Lotz,M.; Setareh,M.; von,Kempis J.; Schwarz,H.. The nerve growth factor/tumor necrosis factor receptor family. J.Leukoc.Biol. 1996;60:1-7. (Link)
Kwon,B.S.; Weissman,S.M.. cDNA sequences of two inducible T-cell genes. Proc.Natl.Acad.Sci.U S A 1989;86:1963-1967. (Link)
Sica,G.; Chen,L.. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy 112. Arch.Immunol.Ther.Exp.(Warsz.) 1999;47:275-279. (Link)
Michel,J.; Langstein,J.; Hofstadter,F.; Schwarz,H.. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur.J.Immunol. 1998;28:290-295. (Link)
Simon,H.U.. Evidence for a pro-apoptotic function of CD137 in granulocytes. Swiss.Med.Wkly. 2001;131:455-458. (Link)
Smith,C.A.; Farrah,T.; Goodwin,R.G.. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76:959-962. (Link)
Michel,J.; Schwarz,H.. Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes. Cytokine 2000;12:742-746. (Link)
Gruss,H.J.; Dower,S.K.. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995;85:3378-3404. (Link)